Latest News - HCA Healthcare

Top Corporates Hub

HCA Healthcare

HCA | NYSE | United States
215
-29
Rank
$85.53B
Market Cap
$70.60B
+$ 5.64B
+8.68%
Revenue
$10.58B
+$ 4.82B
+83.68%
Earnings
226K
-84K
-27.1%
Employees
HCA Healthcare (HCA) Could Be 35% Undervalued Following Downgrades And Index Exits

09.07.2026 03:15

Why HCA Healthcare’s index exits and rating changes matter now HCA Healthcare (HCA) is back on investors’ radar after a cluster of events, including index removals and a Barclays downgrade, raised questions about sentiment around the stock. Over the past six months, HCA Healthcare’s share price decline of 11.6% contrasts with the S&P 500’s 9% gain, and that underperformance is now intersecting with fresh signals from Wall Street and index providers. See our latest analysis for HCA...

Read More

HCA Healthcare (HCA) Publishes Gene Editing Research For Children With Severe Blood Disorders

09.07.2026 00:23

HCA Healthcare (NYSE:HCA) has published new research on gene-editing therapy for children with severe sickle cell disease and beta thalassemia. The study appears in The New England Journal of Medicine and focuses on advanced treatments for high-acuity pediatric blood disorders. The findings highlight HCA Healthcare's work in gene-editing approaches within its broader clinical research programs. For investors watching hospital operators, HCA Healthcare stands out for its focus on complex...

Read More

How HCA Healthcare’s (HCA) Advanced Therapy Research Highlights Its High-Acuity Care Capabilities

07.07.2026 07:13

HCA Healthcare, Inc. (NYSE:HCA) is one of the best medical care facilities stocks to buy according to analysts. The company ranks tenth on the list, with analysts seeing roughly 21.9% upside on average. The latest relevant development was clinical rather than purely financial: on June 29, HCA Healthcare announced new research published in The New […]

Read More

Universal Health Services: From A Cash Trap To A Value Trap

06.07.2026 03:27

Universal Health Services (UHS) rated Hold: low valuation but weak cash conversion, rising receivables, and margin pressure from policy headwinds.

Read More

1 Value Stock for Long-Term Investors and 2 Facing Challenges

03.07.2026 11:30

Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.

Read More

HCA Healthcare (HCA) Reports Promising Gene-Editing Therapy Study Results

01.07.2026 14:48

HCA Healthcare, Inc. (NYSE:HCA) is one of the 10 Most Undervalued American Stocks to Invest In. On June 29, 2026, HCA Healthcare, Inc. (NYSE:HCA) announced new research published in The New England Journal of Medicine showing promising results from a gene-editing therapy being investigated in children ages 5-11 with severe sickle cell disease and transfusion-dependent […]

Read More

HCA Healthcare (HCA): 12 Best Value Stocks to Buy Right Now

01.07.2026 10:23

HCA Healthcare Inc. (NYSE:HCA) is one of the best value stocks to buy right now. On June 29, HCA Healthcare announced research published in the New England Journal of Medicine showing the efficacy of CRISPR-based gene-editing therapy (exa-cel) in children ages 5–11 with severe sickle cell disease and transfusion-dependent beta thalassemia. Lead author Dr. Haydar […]

Read More

HCA Healthcare (HCA) Expands Pediatric Gene Editing Access After Journal Study

01.07.2026 07:16

HCA Healthcare (NYSE:HCA) published new research on a CRISPR-based gene-editing therapy in children aged 5 to 11 with severe blood disorders. The findings, featured in The New England Journal of Medicine, showed positive outcomes in a patient group younger than those covered by existing approvals. The company is extending access to this therapy across its transplant and cellular therapy programs within its hospital network. HCA Healthcare operates one of the largest hospital and specialty...

Read More

How Removal From Key Russell Growth Indexes Will Impact HCA Healthcare (HCA) Investors

30.06.2026 12:07

In late June 2026, HCA Healthcare, Inc. was removed from several major Russell growth indexes, including the Russell Top 200 Growth and Russell 1000 Growth benchmarks, following the latest index rebalancing. This wave of index deletions matters because it can force mechanical selling by index-tracking funds, potentially amplifying short-term trading volume around HCA Healthcare’s shares. We’ll now examine how HCA Healthcare’s removal from key Russell growth indexes may influence the...

Read More

TD Cowen Cuts PT on HCA Healthcare (HCA) But Remains Bullish

28.06.2026 16:46

HCA Healthcare, Inc. (NYSE:HCA) is one of the best non-tech stocks to buy according to analysts. TD Cowen cut the price target on HCA Healthcare, Inc. (NYSE:HCA) to $431 from $500 on June 22 and maintained a Buy rating on the shares. The firm told investors in a research note that it reduced the company’s 2026 and […]

Read More

3 Surefire Stocks to Buy on the Dip and Hold for a Decade

27.06.2026 06:50

As a wise man once said, it's important to "be greedy when others are fearful."

Read More

Has Community Health Found the Right Prescription for its Debt Burden?

23.06.2026 16:13

CYH has cut billions in debt, but can improving operations keep the turnaround alive and ease leverage concerns?

Read More

Is Universal Health Stock Underperforming the Dow?

19.06.2026 09:48

Universal Health has underperformed the Dow Jones Industrial Average over the past year, yet Wall Street remains optimistic about the stock.

Read More

Michael Burry Loads Up On HCA, Says Selloff Created A Buying Opportunity — ‘Insanely Efficient Compounder'

09.06.2026 10:27

Burry said in his latest Substack post that Wall Street's short-term focus has created a buying opportunity in HCA.

Read More

Are Options Traders Betting on a Big Move in HCA Healthcare Stock?

04.06.2026 12:52

Investors need to pay close attention to HCA stock based on the movements in the options market lately.

Read More

HCA Healthcare Cigna Pact And Clinic Expansion Reshape Growth And Valuation Story

04.06.2026 08:13

HCA Healthcare and Cigna reached a new agreement that keeps HCA facilities in network for Cigna members after a period of contract uncertainty. HCA Healthcare is acquiring 17 urgent care clinics across the Carolinas, expanding its footprint in outpatient and same day care. The company is opening new facilities, including a satellite fertility clinic in London and a new hospital in Gainesville. For investors tracking NYSE:HCA, the latest news comes against a mixed share performance backdrop...

Read More

Is HCA Healthcare Stock Underperforming the S&P 500?

02.06.2026 13:28

Despite HCA Healthcare’s underperformance relative to the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.

Read More

HCA Healthcare (HCA) Is Down 6.8% After Q1 EBITDA Miss And Workforce Cuts Are Announced

24.05.2026 10:07

In recent months, HCA Healthcare has reported weaker-than-expected Q1 2026 adjusted EBITDA amid cost pressures and workforce reductions, even as it continued investing in stroke care quality, community initiatives, and new facilities like the HCA Florida Gainesville Hospital. These developments highlight a tension between HCA Healthcare's operational and community expansion efforts and investor concerns about expenses, regulatory headwinds, and the impact of non-clinical layoffs on future...

Read More

HCA Healthcare, Inc. (HCA) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

20.05.2026 14:11

HCA Healthcare, Inc. (HCA) RBC Capital Markets Global Healthcare Conference 2026 May 20, 2026 11:30 AM EDTCompany ParticipantsChristopher Wyatt - Senior VP,...

Read More

Commure Raises $70M at $7B Valuation to Transform Healthcare Operations Using AI

19.05.2026 13:04

MOUNTAIN VIEW, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- Commure, the AI platform for healthcare, today announced $70 million in financing at a $7 billion post-money valuation. The round was led by General Catalyst, with participation from Sequoia Capital, Morgan Stanley, and Kirkland & Ellis. Commure deploys advanced AI and Agents across health systems and practices transforming the day-to-day lives of providers and healthcare administrators. The company is focused on one of the largest cost cen

Read More